Glen Eagle Advisors LLC Sells 980 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Glen Eagle Advisors LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.8% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 5,643 shares of the healthcare conglomerate's stock after selling 980 shares during the period. Glen Eagle Advisors LLC's holdings in UnitedHealth Group were worth $2,855,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Waycross Partners LLC lifted its stake in shares of UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after purchasing an additional 658 shares during the period. Sherbrooke Park Advisers LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at about $515,000. Full Sail Capital LLC increased its position in UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after buying an additional 33 shares in the last quarter. Lmcg Investments LLC increased its holdings in UnitedHealth Group by 11.8% during the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock worth $19,210,000 after purchasing an additional 4,022 shares in the last quarter. Finally, Soros Fund Management LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $39,413,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 1.9%

NYSE:UNH opened at $321.76 on Wednesday. The firm's 50-day moving average price is $464.33 and its 200-day moving average price is $510.17. The company has a market capitalization of $291.88 billion, a PE ratio of 20.76, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the company earned $6.91 earnings per share. On average, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 2.61%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is 35.18%.

Insider Buying and Selling

In other news, CFO John F. Rex bought 17,175 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was bought at an average cost of $291.12 per share, with a total value of $4,999,986.00. Following the acquisition, the chief financial officer now owns 203,796 shares of the company's stock, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy Patrick Flynn bought 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock worth $31,607,768 in the last quarter. Corporate insiders own 0.33% of the company's stock.

Analyst Ratings Changes

Several research firms have recently issued reports on UNH. Bank of America lowered UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their target price for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a report on Monday. TD Securities reaffirmed a "hold" rating and issued a $308.00 target price (down from $520.00) on shares of UnitedHealth Group in a report on Monday. Royal Bank of Canada dropped their price objective on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Finally, JPMorgan Chase & Co. dropped their target price on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating on the stock in a research report on Thursday, May 15th. Eight research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $451.43.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.